nodes	percent_of_prediction	percent_of_DWPC	metapath
Amiodarone—Cytochrome P450 2D6 Inhibitors—Clobazam—epilepsy syndrome	0.274	0.697	CiPCiCtD
Amiodarone—P-Glycoprotein Inhibitors—Zonisamide—epilepsy syndrome	0.119	0.303	CiPCiCtD
Amiodarone—CACNA2D2—epilepsy syndrome	0.114	0.519	CbGaD
Amiodarone—CACNA1H—epilepsy syndrome	0.0673	0.307	CbGaD
Amiodarone—CACNA2D2—Pregabalin—epilepsy syndrome	0.0491	0.191	CbGbCtD
Amiodarone—CACNA2D2—Gabapentin—epilepsy syndrome	0.034	0.133	CbGbCtD
Amiodarone—CYP2C19—epilepsy syndrome	0.0168	0.0767	CbGaD
Amiodarone—CACNA1H—Zonisamide—epilepsy syndrome	0.0127	0.0495	CbGbCtD
Amiodarone—CYP2D6—epilepsy syndrome	0.0125	0.0569	CbGaD
Amiodarone—ABCB1—epilepsy syndrome	0.00891	0.0406	CbGaD
Amiodarone—CYP2A6—Amobarbital—epilepsy syndrome	0.00507	0.0198	CbGbCtD
Amiodarone—CYP2A6—Propofol—epilepsy syndrome	0.00378	0.0147	CbGbCtD
Amiodarone—CYP3A5—Oxcarbazepine—epilepsy syndrome	0.00369	0.0144	CbGbCtD
Amiodarone—CYP2A6—Phenobarbital—epilepsy syndrome	0.00361	0.0141	CbGbCtD
Amiodarone—CYP2C8—Trimethadione—epilepsy syndrome	0.0033	0.0129	CbGbCtD
Amiodarone—CYP1A1—Propofol—epilepsy syndrome	0.00323	0.0126	CbGbCtD
Amiodarone—CYP2C8—Fosphenytoin—epilepsy syndrome	0.0031	0.0121	CbGbCtD
Amiodarone—CYP3A7—Carbamazepine—epilepsy syndrome	0.00309	0.012	CbGbCtD
Amiodarone—CYP3A7-CYP3A51P—Carbamazepine—epilepsy syndrome	0.00309	0.012	CbGbCtD
Amiodarone—CYP1A1—Phenobarbital—epilepsy syndrome	0.00309	0.012	CbGbCtD
Amiodarone—CYP2C19—Oxcarbazepine—epilepsy syndrome	0.00298	0.0116	CbGbCtD
Amiodarone—CYP3A7-CYP3A51P—Phenytoin—epilepsy syndrome	0.00277	0.0108	CbGbCtD
Amiodarone—CYP3A7—Phenytoin—epilepsy syndrome	0.00277	0.0108	CbGbCtD
Amiodarone—CYP2C19—Felbamate—epilepsy syndrome	0.00277	0.0108	CbGbCtD
Amiodarone—CYP2C19—Trimethadione—epilepsy syndrome	0.00277	0.0108	CbGbCtD
Amiodarone—CYP2A6—Valproic Acid—epilepsy syndrome	0.0027	0.0105	CbGbCtD
Amiodarone—ABCB1—Levetiracetam—epilepsy syndrome	0.00263	0.0102	CbGbCtD
Amiodarone—CYP2C19—Fosphenytoin—epilepsy syndrome	0.0026	0.0101	CbGbCtD
Amiodarone—CYP3A7-CYP3A51P—Phenobarbital—epilepsy syndrome	0.00247	0.00962	CbGbCtD
Amiodarone—CYP3A7—Phenobarbital—epilepsy syndrome	0.00247	0.00962	CbGbCtD
Amiodarone—CYP3A7—Midazolam—epilepsy syndrome	0.00244	0.00949	CbGbCtD
Amiodarone—CYP3A7-CYP3A51P—Midazolam—epilepsy syndrome	0.00244	0.00949	CbGbCtD
Amiodarone—CYP3A7—Diazepam—epilepsy syndrome	0.00234	0.00912	CbGbCtD
Amiodarone—CYP3A7-CYP3A51P—Diazepam—epilepsy syndrome	0.00234	0.00912	CbGbCtD
Amiodarone—CYP3A5—Carbamazepine—epilepsy syndrome	0.00232	0.00903	CbGbCtD
Amiodarone—CYP2C9—Trimethadione—epilepsy syndrome	0.0023	0.00897	CbGbCtD
Amiodarone—CYP2C19—Clobazam—epilepsy syndrome	0.00226	0.00879	CbGbCtD
Amiodarone—CYP2C8—Carbamazepine—epilepsy syndrome	0.00223	0.00868	CbGbCtD
Amiodarone—CYP2C9—Fosphenytoin—epilepsy syndrome	0.00216	0.00843	CbGbCtD
Amiodarone—CYP2C8—Primidone—epilepsy syndrome	0.00208	0.00811	CbGbCtD
Amiodarone—CYP3A5—Phenytoin—epilepsy syndrome	0.00208	0.0081	CbGbCtD
Amiodarone—CYP2C8—Phenytoin—epilepsy syndrome	0.002	0.00779	CbGbCtD
Amiodarone—CYP2C19—Carbamazepine—epilepsy syndrome	0.00187	0.00728	CbGbCtD
Amiodarone—CYP2C8—Propofol—epilepsy syndrome	0.00186	0.00726	CbGbCtD
Amiodarone—CYP3A5—Phenobarbital—epilepsy syndrome	0.00185	0.00722	CbGbCtD
Amiodarone—CYP3A5—Midazolam—epilepsy syndrome	0.00183	0.00712	CbGbCtD
Amiodarone—ABCB1—Clobazam—epilepsy syndrome	0.00182	0.00709	CbGbCtD
Amiodarone—CYP2C8—Phenobarbital—epilepsy syndrome	0.00178	0.00694	CbGbCtD
Amiodarone—CYP3A5—Diazepam—epilepsy syndrome	0.00176	0.00684	CbGbCtD
Amiodarone—ABCB1—Lamotrigine—epilepsy syndrome	0.00175	0.00683	CbGbCtD
Amiodarone—CYP2C19—Primidone—epilepsy syndrome	0.00175	0.0068	CbGbCtD
Amiodarone—CYP1A2—Carbamazepine—epilepsy syndrome	0.00172	0.00672	CbGbCtD
Amiodarone—CYP2C8—Diazepam—epilepsy syndrome	0.00169	0.00658	CbGbCtD
Amiodarone—CYP2C19—Phenytoin—epilepsy syndrome	0.00168	0.00653	CbGbCtD
Amiodarone—CYP1A2—Primidone—epilepsy syndrome	0.00161	0.00628	CbGbCtD
Amiodarone—CYP2C19—Propofol—epilepsy syndrome	0.00156	0.00609	CbGbCtD
Amiodarone—CYP2C9—Carbamazepine—epilepsy syndrome	0.00155	0.00606	CbGbCtD
Amiodarone—ABCB1—Carbamazepine—epilepsy syndrome	0.00151	0.00588	CbGbCtD
Amiodarone—CYP2C19—Phenobarbital—epilepsy syndrome	0.00149	0.00582	CbGbCtD
Amiodarone—CYP2C9—Primidone—epilepsy syndrome	0.00145	0.00565	CbGbCtD
Amiodarone—CYP1A2—Propofol—epilepsy syndrome	0.00144	0.00562	CbGbCtD
Amiodarone—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00144	0.00561	CbGbCtD
Amiodarone—CYP2C19—Diazepam—epilepsy syndrome	0.00142	0.00552	CbGbCtD
Amiodarone—CYP2C9—Phenytoin—epilepsy syndrome	0.00139	0.00543	CbGbCtD
Amiodarone—CYP3A5—Valproic Acid—epilepsy syndrome	0.00138	0.0054	CbGbCtD
Amiodarone—CYP2C19—Zonisamide—epilepsy syndrome	0.00138	0.00539	CbGbCtD
Amiodarone—CYP1A2—Phenobarbital—epilepsy syndrome	0.00138	0.00537	CbGbCtD
Amiodarone—ABCB1—Phenytoin—epilepsy syndrome	0.00135	0.00527	CbGbCtD
Amiodarone—CYP3A4—Trimethadione—epilepsy syndrome	0.00134	0.00521	CbGbCtD
Amiodarone—CYP3A4—Felbamate—epilepsy syndrome	0.00134	0.00521	CbGbCtD
Amiodarone—CYP2C8—Valproic Acid—epilepsy syndrome	0.00133	0.00519	CbGbCtD
Amiodarone—CYP1A2—Diazepam—epilepsy syndrome	0.00131	0.00509	CbGbCtD
Amiodarone—CYP2C9—Propofol—epilepsy syndrome	0.0013	0.00507	CbGbCtD
Amiodarone—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00126	0.0049	CbGbCtD
Amiodarone—CYP2C9—Phenobarbital—epilepsy syndrome	0.00124	0.00484	CbGbCtD
Amiodarone—ABCB1—Phenobarbital—epilepsy syndrome	0.00121	0.0047	CbGbCtD
Amiodarone—ABCB1—Midazolam—epilepsy syndrome	0.00119	0.00463	CbGbCtD
Amiodarone—CYP2D6—Propofol—epilepsy syndrome	0.00119	0.00463	CbGbCtD
Amiodarone—CYP2C9—Diazepam—epilepsy syndrome	0.00118	0.00459	CbGbCtD
Amiodarone—ABCB1—Diazepam—epilepsy syndrome	0.00114	0.00445	CbGbCtD
Amiodarone—CYP3A4—Clonazepam—epilepsy syndrome	0.00114	0.00443	CbGbCtD
Amiodarone—CYP2C19—Valproic Acid—epilepsy syndrome	0.00112	0.00435	CbGbCtD
Amiodarone—CYP3A4—Clobazam—epilepsy syndrome	0.00109	0.00425	CbGbCtD
Amiodarone—CYP1A2—Valproic Acid—epilepsy syndrome	0.00103	0.00402	CbGbCtD
Amiodarone—CYP2C19—Topiramate—epilepsy syndrome	0.00101	0.00393	CbGbCtD
Amiodarone—CYP2C9—Valproic Acid—epilepsy syndrome	0.000928	0.00362	CbGbCtD
Amiodarone—CYP3A4—Rufinamide—epilepsy syndrome	0.000927	0.00361	CbGbCtD
Amiodarone—CYP3A4—Carbamazepine—epilepsy syndrome	0.000904	0.00352	CbGbCtD
Amiodarone—CYP3A4—Primidone—epilepsy syndrome	0.000844	0.00329	CbGbCtD
Amiodarone—CYP3A4—Phenytoin—epilepsy syndrome	0.000811	0.00316	CbGbCtD
Amiodarone—CYP3A4—Propofol—epilepsy syndrome	0.000756	0.00295	CbGbCtD
Amiodarone—CYP3A4—Phenobarbital—epilepsy syndrome	0.000722	0.00282	CbGbCtD
Amiodarone—CYP3A4—Acetazolamide—epilepsy syndrome	0.000722	0.00282	CbGbCtD
Amiodarone—CYP3A4—Midazolam—epilepsy syndrome	0.000712	0.00278	CbGbCtD
Amiodarone—CYP3A4—Diazepam—epilepsy syndrome	0.000685	0.00267	CbGbCtD
Amiodarone—CYP3A4—Zonisamide—epilepsy syndrome	0.000668	0.0026	CbGbCtD
Amiodarone—THRB—hindbrain—epilepsy syndrome	0.000663	0.0591	CbGeAlD
Amiodarone—THRA—hindbrain—epilepsy syndrome	0.000663	0.0591	CbGeAlD
Amiodarone—Lucanthone—APEX1—epilepsy syndrome	0.000549	0.221	CrCbGaD
Amiodarone—CYP3A4—Valproic Acid—epilepsy syndrome	0.00054	0.0021	CbGbCtD
Amiodarone—CYP3A4—Topiramate—epilepsy syndrome	0.000487	0.0019	CbGbCtD
Amiodarone—EBP—Bortezomib—Lacosamide—epilepsy syndrome	0.000396	1	CbGdCrCtD
Amiodarone—THRB—brainstem—epilepsy syndrome	0.00038	0.0339	CbGeAlD
Amiodarone—THRA—brainstem—epilepsy syndrome	0.00038	0.0339	CbGeAlD
Amiodarone—THRB—forebrain—epilepsy syndrome	0.000367	0.0327	CbGeAlD
Amiodarone—THRA—forebrain—epilepsy syndrome	0.000367	0.0327	CbGeAlD
Amiodarone—Dronedarone—HCN1—epilepsy syndrome	0.000343	0.138	CrCbGaD
Amiodarone—THRA—telencephalon—epilepsy syndrome	0.000337	0.0301	CbGeAlD
Amiodarone—CACNA2D2—telencephalon—epilepsy syndrome	0.000334	0.0298	CbGeAlD
Amiodarone—Dronedarone—CACNB4—epilepsy syndrome	0.000291	0.117	CrCbGaD
Amiodarone—CACNA2D2—midbrain—epilepsy syndrome	0.00024	0.0214	CbGeAlD
Amiodarone—THRA—spinal cord—epilepsy syndrome	0.000236	0.0211	CbGeAlD
Amiodarone—CACNA2D2—spinal cord—epilepsy syndrome	0.000234	0.0209	CbGeAlD
Amiodarone—THRB—head—epilepsy syndrome	0.00021	0.0187	CbGeAlD
Amiodarone—THRA—head—epilepsy syndrome	0.00021	0.0187	CbGeAlD
Amiodarone—CACNA2D2—head—epilepsy syndrome	0.000208	0.0185	CbGeAlD
Amiodarone—THRB—nervous system—epilepsy syndrome	0.000199	0.0178	CbGeAlD
Amiodarone—THRA—nervous system—epilepsy syndrome	0.000199	0.0178	CbGeAlD
Amiodarone—Proparacaine—SCN3A—epilepsy syndrome	0.000199	0.0801	CrCbGaD
Amiodarone—CACNA2D2—nervous system—epilepsy syndrome	0.000197	0.0176	CbGeAlD
Amiodarone—THRA—central nervous system—epilepsy syndrome	0.000192	0.0171	CbGeAlD
Amiodarone—THRB—central nervous system—epilepsy syndrome	0.000192	0.0171	CbGeAlD
Amiodarone—CACNA2D2—central nervous system—epilepsy syndrome	0.00019	0.0169	CbGeAlD
Amiodarone—THRB—cerebellum—epilepsy syndrome	0.000187	0.0167	CbGeAlD
Amiodarone—THRA—cerebellum—epilepsy syndrome	0.000187	0.0167	CbGeAlD
Amiodarone—CACNA2D2—cerebellum—epilepsy syndrome	0.000185	0.0165	CbGeAlD
Amiodarone—Oxybuprocaine—SCN3A—epilepsy syndrome	0.000182	0.0733	CrCbGaD
Amiodarone—ADRB1—forebrain—epilepsy syndrome	0.000175	0.0156	CbGeAlD
Amiodarone—ADRB1—telencephalon—epilepsy syndrome	0.000161	0.0144	CbGeAlD
Amiodarone—CACNA1H—nervous system—epilepsy syndrome	0.00016	0.0143	CbGeAlD
Amiodarone—SIGMAR1—telencephalon—epilepsy syndrome	0.000154	0.0138	CbGeAlD
Amiodarone—THRB—brain—epilepsy syndrome	0.000152	0.0136	CbGeAlD
Amiodarone—THRA—brain—epilepsy syndrome	0.000152	0.0136	CbGeAlD
Amiodarone—CACNA2D2—brain—epilepsy syndrome	0.000151	0.0134	CbGeAlD
Amiodarone—CACNA1H—cerebellum—epilepsy syndrome	0.00015	0.0134	CbGeAlD
Amiodarone—CYP2D6—hindbrain—epilepsy syndrome	0.000147	0.0131	CbGeAlD
Amiodarone—Proparacaine—SCN1A—epilepsy syndrome	0.00014	0.0563	CrCbGaD
Amiodarone—KCNH2—forebrain—epilepsy syndrome	0.000134	0.0119	CbGeAlD
Amiodarone—Oxybuprocaine—SCN1A—epilepsy syndrome	0.000128	0.0515	CrCbGaD
Amiodarone—Proparacaine—SCN2A—epilepsy syndrome	0.000123	0.0496	CrCbGaD
Amiodarone—KCNH2—telencephalon—epilepsy syndrome	0.000123	0.011	CbGeAlD
Amiodarone—CACNA1H—brain—epilepsy syndrome	0.000122	0.0109	CbGeAlD
Amiodarone—SIGMAR1—medulla oblongata—epilepsy syndrome	0.000121	0.0108	CbGeAlD
Amiodarone—Dronedarone—CACNA1D—epilepsy syndrome	0.000116	0.0467	CrCbGaD
Amiodarone—Oxybuprocaine—SCN2A—epilepsy syndrome	0.000113	0.0454	CrCbGaD
Amiodarone—CYP2A6—cerebellum—epilepsy syndrome	0.000111	0.00993	CbGeAlD
Amiodarone—SIGMAR1—midbrain—epilepsy syndrome	0.000111	0.00989	CbGeAlD
Amiodarone—SIGMAR1—spinal cord—epilepsy syndrome	0.000108	0.00965	CbGeAlD
Amiodarone—ADRB1—head—epilepsy syndrome	0.0001	0.00894	CbGeAlD
Amiodarone—Dronedarone—SCN1A—epilepsy syndrome	9.78e-05	0.0394	CrCbGaD
Amiodarone—KCNH2—medulla oblongata—epilepsy syndrome	9.65e-05	0.00861	CbGeAlD
Amiodarone—ADRB1—nervous system—epilepsy syndrome	9.5e-05	0.00847	CbGeAlD
Amiodarone—ADRB1—central nervous system—epilepsy syndrome	9.14e-05	0.00816	CbGeAlD
Amiodarone—CYP2A6—brain—epilepsy syndrome	9.04e-05	0.00806	CbGeAlD
Amiodarone—KCNH2—midbrain—epilepsy syndrome	8.82e-05	0.00787	CbGeAlD
Amiodarone—KCNH2—spinal cord—epilepsy syndrome	8.61e-05	0.00768	CbGeAlD
Amiodarone—SIGMAR1—cerebellum—epilepsy syndrome	8.58e-05	0.00765	CbGeAlD
Amiodarone—CYP2D6—brainstem—epilepsy syndrome	8.44e-05	0.00753	CbGeAlD
Amiodarone—CYP2D6—forebrain—epilepsy syndrome	8.15e-05	0.00727	CbGeAlD
Amiodarone—KCNH2—head—epilepsy syndrome	7.65e-05	0.00683	CbGeAlD
Amiodarone—CYP2D6—telencephalon—epilepsy syndrome	7.49e-05	0.00668	CbGeAlD
Amiodarone—ADRB1—brain—epilepsy syndrome	7.26e-05	0.00648	CbGeAlD
Amiodarone—KCNH2—nervous system—epilepsy syndrome	7.25e-05	0.00647	CbGeAlD
Amiodarone—KCNH2—central nervous system—epilepsy syndrome	6.98e-05	0.00623	CbGeAlD
Amiodarone—SIGMAR1—brain—epilepsy syndrome	6.97e-05	0.00621	CbGeAlD
Amiodarone—KCNH2—cerebellum—epilepsy syndrome	6.83e-05	0.00609	CbGeAlD
Amiodarone—CYP1A1—head—epilepsy syndrome	6.46e-05	0.00576	CbGeAlD
Amiodarone—CYP1A1—nervous system—epilepsy syndrome	6.13e-05	0.00547	CbGeAlD
Amiodarone—CYP1A1—central nervous system—epilepsy syndrome	5.9e-05	0.00526	CbGeAlD
Amiodarone—ABCB1—forebrain—epilepsy syndrome	5.86e-05	0.00523	CbGeAlD
Amiodarone—KCNH2—brain—epilepsy syndrome	5.54e-05	0.00495	CbGeAlD
Amiodarone—Oxybuprocaine—BCHE—epilepsy syndrome	5.42e-05	0.0218	CrCbGaD
Amiodarone—ABCB1—telencephalon—epilepsy syndrome	5.39e-05	0.00481	CbGeAlD
Amiodarone—CYP2C8—brain—epilepsy syndrome	5.07e-05	0.00453	CbGeAlD
Amiodarone—Cinchocaine—BCHE—epilepsy syndrome	4.81e-05	0.0194	CrCbGaD
Amiodarone—CYP1A1—brain—epilepsy syndrome	4.68e-05	0.00418	CbGeAlD
Amiodarone—CYP2D6—head—epilepsy syndrome	4.67e-05	0.00416	CbGeAlD
Amiodarone—CYP3A4—nervous system—epilepsy syndrome	4.49e-05	0.00401	CbGeAlD
Amiodarone—CYP2D6—nervous system—epilepsy syndrome	4.42e-05	0.00395	CbGeAlD
Amiodarone—CYP3A4—central nervous system—epilepsy syndrome	4.33e-05	0.00386	CbGeAlD
Amiodarone—CYP2D6—central nervous system—epilepsy syndrome	4.26e-05	0.0038	CbGeAlD
Amiodarone—Dronedarone—ADRA2A—epilepsy syndrome	4.25e-05	0.0171	CrCbGaD
Amiodarone—ABCB1—medulla oblongata—epilepsy syndrome	4.23e-05	0.00378	CbGeAlD
Amiodarone—CYP2D6—cerebellum—epilepsy syndrome	4.16e-05	0.00371	CbGeAlD
Amiodarone—ABCB1—midbrain—epilepsy syndrome	3.87e-05	0.00345	CbGeAlD
Amiodarone—ABCB1—spinal cord—epilepsy syndrome	3.78e-05	0.00337	CbGeAlD
Amiodarone—CYP2D6—brain—epilepsy syndrome	3.38e-05	0.00302	CbGeAlD
Amiodarone—ABCB1—head—epilepsy syndrome	3.36e-05	0.00299	CbGeAlD
Amiodarone—ABCB1—nervous system—epilepsy syndrome	3.18e-05	0.00284	CbGeAlD
Amiodarone—ABCB1—central nervous system—epilepsy syndrome	3.06e-05	0.00273	CbGeAlD
Amiodarone—ABCB1—cerebellum—epilepsy syndrome	2.99e-05	0.00267	CbGeAlD
Amiodarone—ABCB1—brain—epilepsy syndrome	2.43e-05	0.00217	CbGeAlD
Amiodarone—Dronedarone—CYP2D6—epilepsy syndrome	2.28e-05	0.00918	CrCbGaD
Amiodarone—Dronedarone—ALB—epilepsy syndrome	1.7e-05	0.00687	CrCbGaD
Amiodarone—Dronedarone—ABCB1—epilepsy syndrome	1.63e-05	0.00655	CrCbGaD
Amiodarone—Abdominal pain—Lamotrigine—epilepsy syndrome	1.58e-05	0.000202	CcSEcCtD
Amiodarone—Body temperature increased—Lamotrigine—epilepsy syndrome	1.58e-05	0.000202	CcSEcCtD
Amiodarone—Dysgeusia—Gabapentin—epilepsy syndrome	1.58e-05	0.000202	CcSEcCtD
Amiodarone—Dizziness—Diazepam—epilepsy syndrome	1.58e-05	0.000202	CcSEcCtD
Amiodarone—Infection—Valproic Acid—epilepsy syndrome	1.58e-05	0.000202	CcSEcCtD
Amiodarone—Rash—Fosphenytoin—epilepsy syndrome	1.57e-05	0.000201	CcSEcCtD
Amiodarone—Dermatitis—Fosphenytoin—epilepsy syndrome	1.57e-05	0.000201	CcSEcCtD
Amiodarone—Asthenia—Clonazepam—epilepsy syndrome	1.56e-05	0.0002	CcSEcCtD
Amiodarone—Back pain—Gabapentin—epilepsy syndrome	1.56e-05	0.0002	CcSEcCtD
Amiodarone—Headache—Fosphenytoin—epilepsy syndrome	1.56e-05	0.0002	CcSEcCtD
Amiodarone—Hepatitis—Topiramate—epilepsy syndrome	1.56e-05	0.0002	CcSEcCtD
Amiodarone—Thrombocytopenia—Valproic Acid—epilepsy syndrome	1.55e-05	0.000199	CcSEcCtD
Amiodarone—Asthenia—Phenytoin—epilepsy syndrome	1.55e-05	0.000199	CcSEcCtD
Amiodarone—Nausea—Midazolam—epilepsy syndrome	1.55e-05	0.000199	CcSEcCtD
Amiodarone—Hallucination—Topiramate—epilepsy syndrome	1.55e-05	0.000199	CcSEcCtD
Amiodarone—Tachycardia—Valproic Acid—epilepsy syndrome	1.55e-05	0.000198	CcSEcCtD
Amiodarone—Diarrhoea—Zonisamide—epilepsy syndrome	1.55e-05	0.000198	CcSEcCtD
Amiodarone—Asthenia—Oxcarbazepine—epilepsy syndrome	1.55e-05	0.000198	CcSEcCtD
Amiodarone—Pruritus—Clonazepam—epilepsy syndrome	1.54e-05	0.000198	CcSEcCtD
Amiodarone—Vomiting—Vigabatrin—epilepsy syndrome	1.54e-05	0.000198	CcSEcCtD
Amiodarone—Skin disorder—Valproic Acid—epilepsy syndrome	1.54e-05	0.000198	CcSEcCtD
Amiodarone—Hyperhidrosis—Valproic Acid—epilepsy syndrome	1.53e-05	0.000197	CcSEcCtD
Amiodarone—Cough—Pregabalin—epilepsy syndrome	1.53e-05	0.000197	CcSEcCtD
Amiodarone—Pruritus—Phenytoin—epilepsy syndrome	1.53e-05	0.000196	CcSEcCtD
Amiodarone—Nausea—Levetiracetam—epilepsy syndrome	1.53e-05	0.000196	CcSEcCtD
Amiodarone—Rash—Vigabatrin—epilepsy syndrome	1.53e-05	0.000196	CcSEcCtD
Amiodarone—Dizziness—Felbamate—epilepsy syndrome	1.53e-05	0.000196	CcSEcCtD
Amiodarone—Dermatitis—Vigabatrin—epilepsy syndrome	1.53e-05	0.000196	CcSEcCtD
Amiodarone—Pruritus—Oxcarbazepine—epilepsy syndrome	1.52e-05	0.000195	CcSEcCtD
Amiodarone—Hypersensitivity—Carbamazepine—epilepsy syndrome	1.52e-05	0.000195	CcSEcCtD
Amiodarone—Vision blurred—Gabapentin—epilepsy syndrome	1.52e-05	0.000195	CcSEcCtD
Amiodarone—Headache—Vigabatrin—epilepsy syndrome	1.52e-05	0.000195	CcSEcCtD
Amiodarone—Vomiting—Diazepam—epilepsy syndrome	1.52e-05	0.000194	CcSEcCtD
Amiodarone—Anorexia—Valproic Acid—epilepsy syndrome	1.51e-05	0.000194	CcSEcCtD
Amiodarone—Tremor—Gabapentin—epilepsy syndrome	1.51e-05	0.000194	CcSEcCtD
Amiodarone—Rash—Diazepam—epilepsy syndrome	1.51e-05	0.000193	CcSEcCtD
Amiodarone—Dermatitis—Diazepam—epilepsy syndrome	1.5e-05	0.000193	CcSEcCtD
Amiodarone—Visual impairment—Topiramate—epilepsy syndrome	1.5e-05	0.000192	CcSEcCtD
Amiodarone—Ill-defined disorder—Gabapentin—epilepsy syndrome	1.5e-05	0.000192	CcSEcCtD
Amiodarone—Dizziness—Zonisamide—epilepsy syndrome	1.5e-05	0.000192	CcSEcCtD
Amiodarone—Headache—Diazepam—epilepsy syndrome	1.5e-05	0.000192	CcSEcCtD
Amiodarone—Anxiety—Pregabalin—epilepsy syndrome	1.49e-05	0.000191	CcSEcCtD
Amiodarone—Diarrhoea—Clonazepam—epilepsy syndrome	1.49e-05	0.000191	CcSEcCtD
Amiodarone—Hypotension—Valproic Acid—epilepsy syndrome	1.48e-05	0.00019	CcSEcCtD
Amiodarone—Asthenia—Carbamazepine—epilepsy syndrome	1.48e-05	0.00019	CcSEcCtD
Amiodarone—Agitation—Gabapentin—epilepsy syndrome	1.48e-05	0.00019	CcSEcCtD
Amiodarone—Diarrhoea—Phenytoin—epilepsy syndrome	1.48e-05	0.00019	CcSEcCtD
Amiodarone—Discomfort—Pregabalin—epilepsy syndrome	1.48e-05	0.000189	CcSEcCtD
Amiodarone—Nausea—Fosphenytoin—epilepsy syndrome	1.48e-05	0.000189	CcSEcCtD
Amiodarone—Diarrhoea—Oxcarbazepine—epilepsy syndrome	1.47e-05	0.000189	CcSEcCtD
Amiodarone—Erythema multiforme—Topiramate—epilepsy syndrome	1.47e-05	0.000189	CcSEcCtD
Amiodarone—Angioedema—Gabapentin—epilepsy syndrome	1.47e-05	0.000189	CcSEcCtD
Amiodarone—Hypersensitivity—Lamotrigine—epilepsy syndrome	1.47e-05	0.000189	CcSEcCtD
Amiodarone—Vomiting—Felbamate—epilepsy syndrome	1.47e-05	0.000188	CcSEcCtD
Amiodarone—Dry mouth—Pregabalin—epilepsy syndrome	1.46e-05	0.000188	CcSEcCtD
Amiodarone—Pruritus—Carbamazepine—epilepsy syndrome	1.46e-05	0.000187	CcSEcCtD
Amiodarone—Rash—Felbamate—epilepsy syndrome	1.46e-05	0.000187	CcSEcCtD
Amiodarone—Dermatitis—Felbamate—epilepsy syndrome	1.46e-05	0.000186	CcSEcCtD
Amiodarone—Malaise—Gabapentin—epilepsy syndrome	1.45e-05	0.000186	CcSEcCtD
Amiodarone—Tinnitus—Topiramate—epilepsy syndrome	1.45e-05	0.000186	CcSEcCtD
Amiodarone—Vertigo—Gabapentin—epilepsy syndrome	1.45e-05	0.000186	CcSEcCtD
Amiodarone—Headache—Felbamate—epilepsy syndrome	1.45e-05	0.000185	CcSEcCtD
Amiodarone—Confusional state—Pregabalin—epilepsy syndrome	1.45e-05	0.000185	CcSEcCtD
Amiodarone—Flushing—Topiramate—epilepsy syndrome	1.45e-05	0.000185	CcSEcCtD
Amiodarone—Dizziness—Clonazepam—epilepsy syndrome	1.44e-05	0.000185	CcSEcCtD
Amiodarone—Nausea—Vigabatrin—epilepsy syndrome	1.44e-05	0.000185	CcSEcCtD
Amiodarone—Vomiting—Zonisamide—epilepsy syndrome	1.44e-05	0.000184	CcSEcCtD
Amiodarone—Insomnia—Valproic Acid—epilepsy syndrome	1.44e-05	0.000184	CcSEcCtD
Amiodarone—Anaphylactic shock—Pregabalin—epilepsy syndrome	1.44e-05	0.000184	CcSEcCtD
Amiodarone—Oedema—Pregabalin—epilepsy syndrome	1.44e-05	0.000184	CcSEcCtD
Amiodarone—Asthenia—Lamotrigine—epilepsy syndrome	1.43e-05	0.000184	CcSEcCtD
Amiodarone—Dizziness—Phenytoin—epilepsy syndrome	1.43e-05	0.000183	CcSEcCtD
Amiodarone—Rash—Zonisamide—epilepsy syndrome	1.43e-05	0.000183	CcSEcCtD
Amiodarone—Infection—Pregabalin—epilepsy syndrome	1.43e-05	0.000183	CcSEcCtD
Amiodarone—Paraesthesia—Valproic Acid—epilepsy syndrome	1.43e-05	0.000183	CcSEcCtD
Amiodarone—Dermatitis—Zonisamide—epilepsy syndrome	1.42e-05	0.000183	CcSEcCtD
Amiodarone—Dizziness—Oxcarbazepine—epilepsy syndrome	1.42e-05	0.000182	CcSEcCtD
Amiodarone—Nausea—Diazepam—epilepsy syndrome	1.42e-05	0.000182	CcSEcCtD
Amiodarone—Headache—Zonisamide—epilepsy syndrome	1.42e-05	0.000182	CcSEcCtD
Amiodarone—Dyspnoea—Valproic Acid—epilepsy syndrome	1.42e-05	0.000181	CcSEcCtD
Amiodarone—Diarrhoea—Carbamazepine—epilepsy syndrome	1.41e-05	0.000181	CcSEcCtD
Amiodarone—Pruritus—Lamotrigine—epilepsy syndrome	1.41e-05	0.000181	CcSEcCtD
Amiodarone—Shock—Pregabalin—epilepsy syndrome	1.41e-05	0.000181	CcSEcCtD
Amiodarone—Cough—Gabapentin—epilepsy syndrome	1.41e-05	0.00018	CcSEcCtD
Amiodarone—Thrombocytopenia—Pregabalin—epilepsy syndrome	1.41e-05	0.00018	CcSEcCtD
Amiodarone—Tachycardia—Pregabalin—epilepsy syndrome	1.4e-05	0.000179	CcSEcCtD
Amiodarone—Dyspepsia—Valproic Acid—epilepsy syndrome	1.4e-05	0.000179	CcSEcCtD
Amiodarone—Skin disorder—Pregabalin—epilepsy syndrome	1.39e-05	0.000179	CcSEcCtD
Amiodarone—Hyperhidrosis—Pregabalin—epilepsy syndrome	1.39e-05	0.000178	CcSEcCtD
Amiodarone—Vomiting—Clonazepam—epilepsy syndrome	1.39e-05	0.000178	CcSEcCtD
Amiodarone—Decreased appetite—Valproic Acid—epilepsy syndrome	1.38e-05	0.000177	CcSEcCtD
Amiodarone—Alopecia—Topiramate—epilepsy syndrome	1.38e-05	0.000176	CcSEcCtD
Amiodarone—Vomiting—Phenytoin—epilepsy syndrome	1.38e-05	0.000176	CcSEcCtD
Amiodarone—Rash—Clonazepam—epilepsy syndrome	1.37e-05	0.000176	CcSEcCtD
Amiodarone—Dermatitis—Clonazepam—epilepsy syndrome	1.37e-05	0.000176	CcSEcCtD
Amiodarone—Nausea—Felbamate—epilepsy syndrome	1.37e-05	0.000176	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	1.37e-05	0.000176	CcSEcCtD
Amiodarone—Vomiting—Oxcarbazepine—epilepsy syndrome	1.37e-05	0.000175	CcSEcCtD
Amiodarone—Fatigue—Valproic Acid—epilepsy syndrome	1.37e-05	0.000175	CcSEcCtD
Amiodarone—Anxiety—Gabapentin—epilepsy syndrome	1.37e-05	0.000175	CcSEcCtD
Amiodarone—Anorexia—Pregabalin—epilepsy syndrome	1.37e-05	0.000175	CcSEcCtD
Amiodarone—Dizziness—Carbamazepine—epilepsy syndrome	1.37e-05	0.000175	CcSEcCtD
Amiodarone—Diarrhoea—Lamotrigine—epilepsy syndrome	1.37e-05	0.000175	CcSEcCtD
Amiodarone—Headache—Clonazepam—epilepsy syndrome	1.37e-05	0.000175	CcSEcCtD
Amiodarone—Rash—Phenytoin—epilepsy syndrome	1.37e-05	0.000175	CcSEcCtD
Amiodarone—Dermatitis—Phenytoin—epilepsy syndrome	1.36e-05	0.000175	CcSEcCtD
Amiodarone—Rash—Oxcarbazepine—epilepsy syndrome	1.36e-05	0.000174	CcSEcCtD
Amiodarone—Constipation—Valproic Acid—epilepsy syndrome	1.36e-05	0.000174	CcSEcCtD
Amiodarone—Pain—Valproic Acid—epilepsy syndrome	1.36e-05	0.000174	CcSEcCtD
Amiodarone—Dermatitis—Oxcarbazepine—epilepsy syndrome	1.36e-05	0.000174	CcSEcCtD
Amiodarone—Headache—Phenytoin—epilepsy syndrome	1.36e-05	0.000174	CcSEcCtD
Amiodarone—Erythema—Topiramate—epilepsy syndrome	1.36e-05	0.000174	CcSEcCtD
Amiodarone—Discomfort—Gabapentin—epilepsy syndrome	1.36e-05	0.000174	CcSEcCtD
Amiodarone—Headache—Oxcarbazepine—epilepsy syndrome	1.35e-05	0.000173	CcSEcCtD
Amiodarone—Nausea—Zonisamide—epilepsy syndrome	1.34e-05	0.000172	CcSEcCtD
Amiodarone—Dry mouth—Gabapentin—epilepsy syndrome	1.34e-05	0.000172	CcSEcCtD
Amiodarone—Hypotension—Pregabalin—epilepsy syndrome	1.34e-05	0.000172	CcSEcCtD
Amiodarone—Dysgeusia—Topiramate—epilepsy syndrome	1.33e-05	0.00017	CcSEcCtD
Amiodarone—Confusional state—Gabapentin—epilepsy syndrome	1.33e-05	0.00017	CcSEcCtD
Amiodarone—Dizziness—Lamotrigine—epilepsy syndrome	1.32e-05	0.000169	CcSEcCtD
Amiodarone—Oedema—Gabapentin—epilepsy syndrome	1.32e-05	0.000169	CcSEcCtD
Amiodarone—Anaphylactic shock—Gabapentin—epilepsy syndrome	1.32e-05	0.000169	CcSEcCtD
Amiodarone—Vomiting—Carbamazepine—epilepsy syndrome	1.31e-05	0.000168	CcSEcCtD
Amiodarone—Back pain—Topiramate—epilepsy syndrome	1.31e-05	0.000168	CcSEcCtD
Amiodarone—Feeling abnormal—Valproic Acid—epilepsy syndrome	1.31e-05	0.000168	CcSEcCtD
Amiodarone—Infection—Gabapentin—epilepsy syndrome	1.31e-05	0.000167	CcSEcCtD
Amiodarone—Rash—Carbamazepine—epilepsy syndrome	1.3e-05	0.000167	CcSEcCtD
Amiodarone—Dermatitis—Carbamazepine—epilepsy syndrome	1.3e-05	0.000167	CcSEcCtD
Amiodarone—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	1.3e-05	0.000166	CcSEcCtD
Amiodarone—Insomnia—Pregabalin—epilepsy syndrome	1.3e-05	0.000166	CcSEcCtD
Amiodarone—Nausea—Clonazepam—epilepsy syndrome	1.29e-05	0.000166	CcSEcCtD
Amiodarone—Headache—Carbamazepine—epilepsy syndrome	1.29e-05	0.000166	CcSEcCtD
Amiodarone—Shock—Gabapentin—epilepsy syndrome	1.29e-05	0.000166	CcSEcCtD
Amiodarone—Paraesthesia—Pregabalin—epilepsy syndrome	1.29e-05	0.000165	CcSEcCtD
Amiodarone—Thrombocytopenia—Gabapentin—epilepsy syndrome	1.29e-05	0.000165	CcSEcCtD
Amiodarone—Nausea—Phenytoin—epilepsy syndrome	1.29e-05	0.000165	CcSEcCtD
Amiodarone—Tachycardia—Gabapentin—epilepsy syndrome	1.28e-05	0.000165	CcSEcCtD
Amiodarone—Dyspnoea—Pregabalin—epilepsy syndrome	1.28e-05	0.000164	CcSEcCtD
Amiodarone—Nausea—Oxcarbazepine—epilepsy syndrome	1.28e-05	0.000164	CcSEcCtD
Amiodarone—Vision blurred—Topiramate—epilepsy syndrome	1.28e-05	0.000164	CcSEcCtD
Amiodarone—Skin disorder—Gabapentin—epilepsy syndrome	1.28e-05	0.000164	CcSEcCtD
Amiodarone—Hyperhidrosis—Gabapentin—epilepsy syndrome	1.27e-05	0.000163	CcSEcCtD
Amiodarone—Tremor—Topiramate—epilepsy syndrome	1.27e-05	0.000163	CcSEcCtD
Amiodarone—Vomiting—Lamotrigine—epilepsy syndrome	1.27e-05	0.000163	CcSEcCtD
Amiodarone—Urticaria—Valproic Acid—epilepsy syndrome	1.26e-05	0.000162	CcSEcCtD
Amiodarone—Rash—Lamotrigine—epilepsy syndrome	1.26e-05	0.000161	CcSEcCtD
Amiodarone—Ill-defined disorder—Topiramate—epilepsy syndrome	1.26e-05	0.000161	CcSEcCtD
Amiodarone—Dermatitis—Lamotrigine—epilepsy syndrome	1.26e-05	0.000161	CcSEcCtD
Amiodarone—Abdominal pain—Valproic Acid—epilepsy syndrome	1.25e-05	0.000161	CcSEcCtD
Amiodarone—Body temperature increased—Valproic Acid—epilepsy syndrome	1.25e-05	0.000161	CcSEcCtD
Amiodarone—Anorexia—Gabapentin—epilepsy syndrome	1.25e-05	0.000161	CcSEcCtD
Amiodarone—Headache—Lamotrigine—epilepsy syndrome	1.25e-05	0.00016	CcSEcCtD
Amiodarone—Decreased appetite—Pregabalin—epilepsy syndrome	1.25e-05	0.00016	CcSEcCtD
Amiodarone—Agitation—Topiramate—epilepsy syndrome	1.25e-05	0.00016	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	1.24e-05	0.000159	CcSEcCtD
Amiodarone—Fatigue—Pregabalin—epilepsy syndrome	1.24e-05	0.000158	CcSEcCtD
Amiodarone—Hypotension—Gabapentin—epilepsy syndrome	1.23e-05	0.000158	CcSEcCtD
Amiodarone—Nausea—Carbamazepine—epilepsy syndrome	1.23e-05	0.000157	CcSEcCtD
Amiodarone—Pain—Pregabalin—epilepsy syndrome	1.23e-05	0.000157	CcSEcCtD
Amiodarone—Constipation—Pregabalin—epilepsy syndrome	1.23e-05	0.000157	CcSEcCtD
Amiodarone—Malaise—Topiramate—epilepsy syndrome	1.22e-05	0.000157	CcSEcCtD
Amiodarone—Vertigo—Topiramate—epilepsy syndrome	1.22e-05	0.000156	CcSEcCtD
Amiodarone—Insomnia—Gabapentin—epilepsy syndrome	1.19e-05	0.000152	CcSEcCtD
Amiodarone—Nausea—Lamotrigine—epilepsy syndrome	1.19e-05	0.000152	CcSEcCtD
Amiodarone—Cough—Topiramate—epilepsy syndrome	1.18e-05	0.000152	CcSEcCtD
Amiodarone—Feeling abnormal—Pregabalin—epilepsy syndrome	1.18e-05	0.000151	CcSEcCtD
Amiodarone—Paraesthesia—Gabapentin—epilepsy syndrome	1.18e-05	0.000151	CcSEcCtD
Amiodarone—Gastrointestinal pain—Pregabalin—epilepsy syndrome	1.17e-05	0.00015	CcSEcCtD
Amiodarone—Dyspnoea—Gabapentin—epilepsy syndrome	1.17e-05	0.00015	CcSEcCtD
Amiodarone—Hypersensitivity—Valproic Acid—epilepsy syndrome	1.17e-05	0.00015	CcSEcCtD
Amiodarone—Dyspepsia—Gabapentin—epilepsy syndrome	1.16e-05	0.000148	CcSEcCtD
Amiodarone—Anxiety—Topiramate—epilepsy syndrome	1.15e-05	0.000147	CcSEcCtD
Amiodarone—Decreased appetite—Gabapentin—epilepsy syndrome	1.14e-05	0.000147	CcSEcCtD
Amiodarone—Discomfort—Topiramate—epilepsy syndrome	1.14e-05	0.000146	CcSEcCtD
Amiodarone—Urticaria—Pregabalin—epilepsy syndrome	1.14e-05	0.000146	CcSEcCtD
Amiodarone—Asthenia—Valproic Acid—epilepsy syndrome	1.14e-05	0.000146	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	1.14e-05	0.000146	CcSEcCtD
Amiodarone—Fatigue—Gabapentin—epilepsy syndrome	1.13e-05	0.000145	CcSEcCtD
Amiodarone—Abdominal pain—Pregabalin—epilepsy syndrome	1.13e-05	0.000145	CcSEcCtD
Amiodarone—Body temperature increased—Pregabalin—epilepsy syndrome	1.13e-05	0.000145	CcSEcCtD
Amiodarone—Dry mouth—Topiramate—epilepsy syndrome	1.13e-05	0.000145	CcSEcCtD
Amiodarone—Constipation—Gabapentin—epilepsy syndrome	1.13e-05	0.000144	CcSEcCtD
Amiodarone—Pain—Gabapentin—epilepsy syndrome	1.13e-05	0.000144	CcSEcCtD
Amiodarone—Pruritus—Valproic Acid—epilepsy syndrome	1.12e-05	0.000144	CcSEcCtD
Amiodarone—Confusional state—Topiramate—epilepsy syndrome	1.12e-05	0.000143	CcSEcCtD
Amiodarone—Oedema—Topiramate—epilepsy syndrome	1.11e-05	0.000142	CcSEcCtD
Amiodarone—Infection—Topiramate—epilepsy syndrome	1.1e-05	0.000141	CcSEcCtD
Amiodarone—Shock—Topiramate—epilepsy syndrome	1.09e-05	0.00014	CcSEcCtD
Amiodarone—Diarrhoea—Valproic Acid—epilepsy syndrome	1.09e-05	0.000139	CcSEcCtD
Amiodarone—Feeling abnormal—Gabapentin—epilepsy syndrome	1.08e-05	0.000139	CcSEcCtD
Amiodarone—Thrombocytopenia—Topiramate—epilepsy syndrome	1.08e-05	0.000139	CcSEcCtD
Amiodarone—Tachycardia—Topiramate—epilepsy syndrome	1.08e-05	0.000138	CcSEcCtD
Amiodarone—Gastrointestinal pain—Gabapentin—epilepsy syndrome	1.08e-05	0.000138	CcSEcCtD
Amiodarone—Skin disorder—Topiramate—epilepsy syndrome	1.08e-05	0.000138	CcSEcCtD
Amiodarone—Hyperhidrosis—Topiramate—epilepsy syndrome	1.07e-05	0.000137	CcSEcCtD
Amiodarone—Hypersensitivity—Pregabalin—epilepsy syndrome	1.06e-05	0.000135	CcSEcCtD
Amiodarone—Anorexia—Topiramate—epilepsy syndrome	1.06e-05	0.000135	CcSEcCtD
Amiodarone—Dizziness—Valproic Acid—epilepsy syndrome	1.05e-05	0.000134	CcSEcCtD
Amiodarone—Urticaria—Gabapentin—epilepsy syndrome	1.05e-05	0.000134	CcSEcCtD
Amiodarone—Body temperature increased—Gabapentin—epilepsy syndrome	1.04e-05	0.000133	CcSEcCtD
Amiodarone—Abdominal pain—Gabapentin—epilepsy syndrome	1.04e-05	0.000133	CcSEcCtD
Amiodarone—Hypotension—Topiramate—epilepsy syndrome	1.03e-05	0.000133	CcSEcCtD
Amiodarone—Asthenia—Pregabalin—epilepsy syndrome	1.03e-05	0.000132	CcSEcCtD
Amiodarone—Pruritus—Pregabalin—epilepsy syndrome	1.02e-05	0.00013	CcSEcCtD
Amiodarone—Vomiting—Valproic Acid—epilepsy syndrome	1.01e-05	0.000129	CcSEcCtD
Amiodarone—Insomnia—Topiramate—epilepsy syndrome	1e-05	0.000128	CcSEcCtD
Amiodarone—Rash—Valproic Acid—epilepsy syndrome	1e-05	0.000128	CcSEcCtD
Amiodarone—Dermatitis—Valproic Acid—epilepsy syndrome	1e-05	0.000128	CcSEcCtD
Amiodarone—Headache—Valproic Acid—epilepsy syndrome	9.94e-06	0.000127	CcSEcCtD
Amiodarone—Paraesthesia—Topiramate—epilepsy syndrome	9.94e-06	0.000127	CcSEcCtD
Amiodarone—Dyspnoea—Topiramate—epilepsy syndrome	9.87e-06	0.000126	CcSEcCtD
Amiodarone—Diarrhoea—Pregabalin—epilepsy syndrome	9.82e-06	0.000126	CcSEcCtD
Amiodarone—Dyspepsia—Topiramate—epilepsy syndrome	9.75e-06	0.000125	CcSEcCtD
Amiodarone—Hypersensitivity—Gabapentin—epilepsy syndrome	9.7e-06	0.000124	CcSEcCtD
Amiodarone—Decreased appetite—Topiramate—epilepsy syndrome	9.62e-06	0.000123	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Topiramate—epilepsy syndrome	9.56e-06	0.000122	CcSEcCtD
Amiodarone—Fatigue—Topiramate—epilepsy syndrome	9.55e-06	0.000122	CcSEcCtD
Amiodarone—Dizziness—Pregabalin—epilepsy syndrome	9.49e-06	0.000122	CcSEcCtD
Amiodarone—Pain—Topiramate—epilepsy syndrome	9.47e-06	0.000121	CcSEcCtD
Amiodarone—Constipation—Topiramate—epilepsy syndrome	9.47e-06	0.000121	CcSEcCtD
Amiodarone—Asthenia—Gabapentin—epilepsy syndrome	9.44e-06	0.000121	CcSEcCtD
Amiodarone—Nausea—Valproic Acid—epilepsy syndrome	9.43e-06	0.000121	CcSEcCtD
Amiodarone—Pruritus—Gabapentin—epilepsy syndrome	9.31e-06	0.000119	CcSEcCtD
Amiodarone—Vomiting—Pregabalin—epilepsy syndrome	9.12e-06	0.000117	CcSEcCtD
Amiodarone—Feeling abnormal—Topiramate—epilepsy syndrome	9.12e-06	0.000117	CcSEcCtD
Amiodarone—Gastrointestinal pain—Topiramate—epilepsy syndrome	9.05e-06	0.000116	CcSEcCtD
Amiodarone—Rash—Pregabalin—epilepsy syndrome	9.05e-06	0.000116	CcSEcCtD
Amiodarone—Dermatitis—Pregabalin—epilepsy syndrome	9.04e-06	0.000116	CcSEcCtD
Amiodarone—Diarrhoea—Gabapentin—epilepsy syndrome	9e-06	0.000115	CcSEcCtD
Amiodarone—Headache—Pregabalin—epilepsy syndrome	8.99e-06	0.000115	CcSEcCtD
Amiodarone—Urticaria—Topiramate—epilepsy syndrome	8.8e-06	0.000113	CcSEcCtD
Amiodarone—Abdominal pain—Topiramate—epilepsy syndrome	8.75e-06	0.000112	CcSEcCtD
Amiodarone—Body temperature increased—Topiramate—epilepsy syndrome	8.75e-06	0.000112	CcSEcCtD
Amiodarone—Dizziness—Gabapentin—epilepsy syndrome	8.7e-06	0.000111	CcSEcCtD
Amiodarone—Nausea—Pregabalin—epilepsy syndrome	8.52e-06	0.000109	CcSEcCtD
Amiodarone—Vomiting—Gabapentin—epilepsy syndrome	8.37e-06	0.000107	CcSEcCtD
Amiodarone—Rash—Gabapentin—epilepsy syndrome	8.3e-06	0.000106	CcSEcCtD
Amiodarone—Dermatitis—Gabapentin—epilepsy syndrome	8.29e-06	0.000106	CcSEcCtD
Amiodarone—Headache—Gabapentin—epilepsy syndrome	8.24e-06	0.000106	CcSEcCtD
Amiodarone—Hypersensitivity—Topiramate—epilepsy syndrome	8.16e-06	0.000104	CcSEcCtD
Amiodarone—Asthenia—Topiramate—epilepsy syndrome	7.94e-06	0.000102	CcSEcCtD
Amiodarone—Pruritus—Topiramate—epilepsy syndrome	7.83e-06	0.0001	CcSEcCtD
Amiodarone—Nausea—Gabapentin—epilepsy syndrome	7.82e-06	0.0001	CcSEcCtD
Amiodarone—Diarrhoea—Topiramate—epilepsy syndrome	7.58e-06	9.7e-05	CcSEcCtD
Amiodarone—Dizziness—Topiramate—epilepsy syndrome	7.32e-06	9.38e-05	CcSEcCtD
Amiodarone—Vomiting—Topiramate—epilepsy syndrome	7.04e-06	9.02e-05	CcSEcCtD
Amiodarone—Rash—Topiramate—epilepsy syndrome	6.98e-06	8.94e-05	CcSEcCtD
Amiodarone—Dermatitis—Topiramate—epilepsy syndrome	6.97e-06	8.93e-05	CcSEcCtD
Amiodarone—Headache—Topiramate—epilepsy syndrome	6.94e-06	8.88e-05	CcSEcCtD
Amiodarone—Nausea—Topiramate—epilepsy syndrome	6.58e-06	8.42e-05	CcSEcCtD
Amiodarone—CYP3A7—Metabolism—ABCB1—epilepsy syndrome	1.36e-06	3.5e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—CCL2—epilepsy syndrome	1.35e-06	3.49e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—CYP2C19—epilepsy syndrome	1.33e-06	3.42e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—TXNRD1—epilepsy syndrome	1.32e-06	3.41e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—CYP11A1—epilepsy syndrome	1.32e-06	3.4e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.31e-06	3.38e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	1.31e-06	3.37e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—ADRA2A—epilepsy syndrome	1.31e-06	3.37e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—BCHE—epilepsy syndrome	1.3e-06	3.36e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.3e-06	3.36e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—CYP2D6—epilepsy syndrome	1.3e-06	3.35e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—HMOX1—epilepsy syndrome	1.3e-06	3.34e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—S100B—epilepsy syndrome	1.29e-06	3.31e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—AQP1—epilepsy syndrome	1.28e-06	3.31e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—CAT—epilepsy syndrome	1.28e-06	3.3e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—SOCS3—epilepsy syndrome	1.27e-06	3.28e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	1.27e-06	3.28e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CDC42—epilepsy syndrome	1.27e-06	3.27e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.27e-06	3.26e-05	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—GPX1—epilepsy syndrome	1.26e-06	3.25e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—ABCB1—epilepsy syndrome	1.24e-06	3.21e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—SLC2A1—epilepsy syndrome	1.24e-06	3.2e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.24e-06	3.2e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—NT5E—epilepsy syndrome	1.24e-06	3.2e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—ALAD—epilepsy syndrome	1.24e-06	3.2e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—ADRA2A—epilepsy syndrome	1.24e-06	3.19e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	1.23e-06	3.18e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—BCHE—epilepsy syndrome	1.23e-06	3.17e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—AVP—epilepsy syndrome	1.23e-06	3.17e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—PLCB1—epilepsy syndrome	1.23e-06	3.17e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—TH—epilepsy syndrome	1.22e-06	3.16e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—ABCG2—epilepsy syndrome	1.22e-06	3.13e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.19e-06	3.08e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—CYP2D6—epilepsy syndrome	1.19e-06	3.07e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—ABCG2—epilepsy syndrome	1.19e-06	3.06e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	1.18e-06	3.05e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	1.18e-06	3.05e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—CYP11A1—epilepsy syndrome	1.18e-06	3.03e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—SLC2A1—epilepsy syndrome	1.17e-06	3.03e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.17e-06	3.01e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—HES1—epilepsy syndrome	1.16e-06	3e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—KCNJ11—epilepsy syndrome	1.16e-06	3e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—CHRM3—epilepsy syndrome	1.16e-06	3e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—PLCB1—epilepsy syndrome	1.16e-06	2.99e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	1.16e-06	2.98e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—TH—epilepsy syndrome	1.16e-06	2.98e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—GPX1—epilepsy syndrome	1.16e-06	2.98e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—CYP2C19—epilepsy syndrome	1.16e-06	2.98e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—CYP11A1—epilepsy syndrome	1.15e-06	2.96e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.14e-06	2.94e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—ADSL—epilepsy syndrome	1.13e-06	2.92e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—ADRA2A—epilepsy syndrome	1.13e-06	2.92e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—FYN—epilepsy syndrome	1.13e-06	2.91e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—BCHE—epilepsy syndrome	1.13e-06	2.91e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—H2AFX—epilepsy syndrome	1.13e-06	2.9e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—MEF2C—epilepsy syndrome	1.12e-06	2.9e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	1.12e-06	2.88e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—GLUL—epilepsy syndrome	1.11e-06	2.87e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	1.11e-06	2.86e-05	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—AGT—epilepsy syndrome	1.11e-06	2.85e-05	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	1.09e-06	2.82e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	1.09e-06	2.81e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	1.09e-06	2.81e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—YWHAZ—epilepsy syndrome	1.09e-06	2.8e-05	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—APOE—epilepsy syndrome	1.08e-06	2.8e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	1.08e-06	2.79e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.08e-06	2.79e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	1.08e-06	2.78e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—SLC2A1—epilepsy syndrome	1.08e-06	2.78e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—NGF—epilepsy syndrome	1.07e-06	2.77e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	1.07e-06	2.77e-05	CbGpPWpGaD
Amiodarone—CACNA2D2—Metabolism—AKT1—epilepsy syndrome	1.07e-06	2.76e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.07e-06	2.75e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.07e-06	2.75e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PLCB1—epilepsy syndrome	1.06e-06	2.74e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—CYP2D6—epilepsy syndrome	1.06e-06	2.74e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—TH—epilepsy syndrome	1.06e-06	2.74e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.06e-06	2.73e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CCR5—epilepsy syndrome	1.05e-06	2.7e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.04e-06	2.69e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	1.04e-06	2.67e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—HTR2A—epilepsy syndrome	1.02e-06	2.64e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—HMOX1—epilepsy syndrome	1.02e-06	2.64e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	1.02e-06	2.63e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—AGT—epilepsy syndrome	1.01e-06	2.61e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—ADRA2A—epilepsy syndrome	1.01e-06	2.61e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—CAT—epilepsy syndrome	1.01e-06	2.6e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—BCHE—epilepsy syndrome	1.01e-06	2.6e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—APOE—epilepsy syndrome	9.94e-07	2.56e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—AQP1—epilepsy syndrome	9.91e-07	2.56e-05	CbGpPWpGaD
Amiodarone—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	9.89e-07	2.55e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	9.87e-07	2.54e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—BCHE—epilepsy syndrome	9.83e-07	2.53e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—ABCB1—epilepsy syndrome	9.81e-07	2.53e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—TSC2—epilepsy syndrome	9.72e-07	2.51e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	9.71e-07	2.5e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—AGT—epilepsy syndrome	9.71e-07	2.5e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	9.69e-07	2.5e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—HMOX1—epilepsy syndrome	9.66e-07	2.49e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—SLC2A1—epilepsy syndrome	9.61e-07	2.48e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—CAT—epilepsy syndrome	9.53e-07	2.46e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—APOE—epilepsy syndrome	9.51e-07	2.45e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PLCB1—epilepsy syndrome	9.5e-07	2.45e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—ABCG2—epilepsy syndrome	9.47e-07	2.44e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—TH—epilepsy syndrome	9.47e-07	2.44e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	9.38e-07	2.42e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	9.32e-07	2.4e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—KDR—epilepsy syndrome	9.32e-07	2.4e-05	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—POMC—epilepsy syndrome	9.31e-07	2.4e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	9.3e-07	2.4e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PLCB1—epilepsy syndrome	9.27e-07	2.39e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—ABCB1—epilepsy syndrome	9.27e-07	2.39e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—BCHE—epilepsy syndrome	9.26e-07	2.39e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—TH—epilepsy syndrome	9.24e-07	2.38e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—CYP2C19—epilepsy syndrome	9.23e-07	2.38e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	9.22e-07	2.38e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—BCHE—epilepsy syndrome	9.18e-07	2.37e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—CYP11A1—epilepsy syndrome	9.17e-07	2.36e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—GPX1—epilepsy syndrome	9.12e-07	2.35e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	9.11e-07	2.35e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—PRKCB—epilepsy syndrome	8.97e-07	2.31e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	8.96e-07	2.31e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	8.96e-07	2.31e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—IL6ST—epilepsy syndrome	8.93e-07	2.3e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—HMOX1—epilepsy syndrome	8.85e-07	2.28e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	8.84e-07	2.28e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	8.76e-07	2.26e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	8.74e-07	2.25e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—CAT—epilepsy syndrome	8.73e-07	2.25e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—TH—epilepsy syndrome	8.71e-07	2.25e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	8.66e-07	2.23e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—TH—epilepsy syndrome	8.63e-07	2.23e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—GPX1—epilepsy syndrome	8.62e-07	2.22e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—POMC—epilepsy syndrome	8.54e-07	2.2e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	8.5e-07	2.19e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—ABCB1—epilepsy syndrome	8.5e-07	2.19e-05	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—ALB—epilepsy syndrome	8.49e-07	2.19e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	8.3e-07	2.14e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—CYP2D6—epilepsy syndrome	8.28e-07	2.13e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—POMC—epilepsy syndrome	8.17e-07	2.11e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—AGT—epilepsy syndrome	8e-07	2.06e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CCL2—epilepsy syndrome	7.99e-07	2.06e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—HMOX1—epilepsy syndrome	7.9e-07	2.04e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—GPX1—epilepsy syndrome	7.9e-07	2.04e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—ADRA2A—epilepsy syndrome	7.88e-07	2.03e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—BCHE—epilepsy syndrome	7.85e-07	2.02e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—APOE—epilepsy syndrome	7.84e-07	2.02e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—CAT—epilepsy syndrome	7.8e-07	2.01e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—ALB—epilepsy syndrome	7.78e-07	2.01e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—HMOX1—epilepsy syndrome	7.71e-07	1.99e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—CAT—epilepsy syndrome	7.61e-07	1.96e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—ABCB1—epilepsy syndrome	7.58e-07	1.96e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—AGT—epilepsy syndrome	7.56e-07	1.95e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—SLC2A1—epilepsy syndrome	7.49e-07	1.93e-05	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—PTGS2—epilepsy syndrome	7.43e-07	1.92e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PLCB1—epilepsy syndrome	7.4e-07	1.91e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—APOE—epilepsy syndrome	7.4e-07	1.91e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—TH—epilepsy syndrome	7.38e-07	1.9e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	7.31e-07	1.88e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	7.27e-07	1.87e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	7.26e-07	1.87e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—FGF2—epilepsy syndrome	7.22e-07	1.86e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	7.2e-07	1.86e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—CAT—epilepsy syndrome	7.17e-07	1.85e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	7.12e-07	1.84e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—CAT—epilepsy syndrome	7.11e-07	1.83e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	7.08e-07	1.82e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—GPX1—epilepsy syndrome	7.05e-07	1.82e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	6.98e-07	1.8e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—AGT—epilepsy syndrome	6.93e-07	1.79e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	6.92e-07	1.78e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—GPX1—epilepsy syndrome	6.88e-07	1.77e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—PTGS2—epilepsy syndrome	6.81e-07	1.76e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—APOE—epilepsy syndrome	6.79e-07	1.75e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—POMC—epilepsy syndrome	6.73e-07	1.74e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—RELA—epilepsy syndrome	6.71e-07	1.73e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—MTOR—epilepsy syndrome	6.58e-07	1.7e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—GPX1—epilepsy syndrome	6.49e-07	1.67e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—GPX1—epilepsy syndrome	6.43e-07	1.66e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	6.39e-07	1.65e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—POMC—epilepsy syndrome	6.36e-07	1.64e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—AGT—epilepsy syndrome	6.18e-07	1.59e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—HMOX1—epilepsy syndrome	6.16e-07	1.59e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—ALB—epilepsy syndrome	6.14e-07	1.58e-05	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—AKT1—epilepsy syndrome	6.11e-07	1.57e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	6.08e-07	1.57e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—CAT—epilepsy syndrome	6.07e-07	1.57e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—APOE—epilepsy syndrome	6.06e-07	1.56e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—BCHE—epilepsy syndrome	6.06e-07	1.56e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CASP3—epilepsy syndrome	6.05e-07	1.56e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—AGT—epilepsy syndrome	6.03e-07	1.56e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—APOE—epilepsy syndrome	5.91e-07	1.52e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—ABCB1—epilepsy syndrome	5.91e-07	1.52e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—JUN—epilepsy syndrome	5.88e-07	1.52e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—POMC—epilepsy syndrome	5.83e-07	1.5e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—ALB—epilepsy syndrome	5.8e-07	1.49e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	5.78e-07	1.49e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—MMP9—epilepsy syndrome	5.72e-07	1.47e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	5.71e-07	1.47e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—TH—epilepsy syndrome	5.69e-07	1.47e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—AGT—epilepsy syndrome	5.69e-07	1.47e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—AGT—epilepsy syndrome	5.64e-07	1.45e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—APOE—epilepsy syndrome	5.57e-07	1.44e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—AKT1—epilepsy syndrome	5.54e-07	1.43e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—APOE—epilepsy syndrome	5.52e-07	1.42e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—GPX1—epilepsy syndrome	5.49e-07	1.42e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—PTGS2—epilepsy syndrome	5.37e-07	1.38e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—ALB—epilepsy syndrome	5.32e-07	1.37e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—SRC—epilepsy syndrome	5.27e-07	1.36e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—POMC—epilepsy syndrome	5.2e-07	1.34e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—VEGFA—epilepsy syndrome	5.13e-07	1.32e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—POMC—epilepsy syndrome	5.08e-07	1.31e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—PTGS2—epilepsy syndrome	5.07e-07	1.31e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—AGT—epilepsy syndrome	4.82e-07	1.24e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—POMC—epilepsy syndrome	4.79e-07	1.23e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	4.75e-07	1.23e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—POMC—epilepsy syndrome	4.75e-07	1.22e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—ALB—epilepsy syndrome	4.74e-07	1.22e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—APOE—epilepsy syndrome	4.72e-07	1.22e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—CAT—epilepsy syndrome	4.69e-07	1.21e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PTGS2—epilepsy syndrome	4.65e-07	1.2e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—ALB—epilepsy syndrome	4.63e-07	1.19e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	4.56e-07	1.18e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—ALB—epilepsy syndrome	4.36e-07	1.13e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—ALB—epilepsy syndrome	4.33e-07	1.12e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—GPX1—epilepsy syndrome	4.24e-07	1.09e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PTGS2—epilepsy syndrome	4.15e-07	1.07e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—POMC—epilepsy syndrome	4.05e-07	1.05e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PTGS2—epilepsy syndrome	4.05e-07	1.04e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	3.82e-07	9.84e-06	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	3.78e-07	9.76e-06	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—AKT1—epilepsy syndrome	3.73e-07	9.63e-06	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—AGT—epilepsy syndrome	3.72e-07	9.59e-06	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—ALB—epilepsy syndrome	3.7e-07	9.53e-06	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—APOE—epilepsy syndrome	3.64e-07	9.39e-06	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—AKT1—epilepsy syndrome	3.42e-07	8.82e-06	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—AKT1—epilepsy syndrome	3.28e-07	8.45e-06	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PTGS2—epilepsy syndrome	3.23e-07	8.34e-06	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—POMC—epilepsy syndrome	3.13e-07	8.07e-06	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—ALB—epilepsy syndrome	2.85e-07	7.36e-06	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—AKT1—epilepsy syndrome	2.7e-07	6.96e-06	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—AKT1—epilepsy syndrome	2.55e-07	6.57e-06	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	2.5e-07	6.44e-06	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—AKT1—epilepsy syndrome	2.34e-07	6.03e-06	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—AKT1—epilepsy syndrome	2.09e-07	5.38e-06	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—AKT1—epilepsy syndrome	2.04e-07	5.25e-06	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—AKT1—epilepsy syndrome	1.92e-07	4.95e-06	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—AKT1—epilepsy syndrome	1.9e-07	4.9e-06	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—AKT1—epilepsy syndrome	1.63e-07	4.19e-06	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—AKT1—epilepsy syndrome	1.25e-07	3.23e-06	CbGpPWpGaD
